Natalie Lam

Natalie Lam

Auto-generated profile, based on publicly available information

Natalie Lam

University of York Department of Health Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2023 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
TCThomas F. Crocker
Thomas F. Crocker
NLNatalie Lam
Natalie Lam
MJMagda Jordão
Magda Jordão
CBCaroline Brundle
Caroline Brundle
MPMatthew Prescott
Matthew Prescott
ACAndrew Clegg
Andrew Clegg
To report our experience using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2). Two reviewers independently applied RoB 2 to results of interest in a large systematic review of complex interventions and reached consensus. We recorded the time taken, and noted and discussed our difficulties using the tool, and the resolutions we adopted. We explored the time taken with regression analysis and summarized our experience of implementing the tool. We assessed risk of bias in 860 results of interest in 113 studies. Staff resource averaged 358 minutes per study (SD 183). Number of results (β = 22) and reports (β = 14) per study and experience of the team (β = -6) significantly affected assessment time. To implement the tool consistently, we developed cut points for missingness and considerations of balance regarding missingness, assumed some concerns with intervention deviations unless otherwise prevented or investigated, some concerns with measurements from unblinded self-reporting participants, and judged low risk of selection for certain dichotomous outcomes despite the absence of an analysis plan. The RoB 2 tool and guidance are useful but resource-intensive and challenging to implement. Critical appraisal tools and reporting guidelines should detail risk of bias implementation. Improved guidance focusing on implementation could assist reviewers.

21 March 2024 in BMJ
Verified
Journal Article
Open access
PDF file
TCThomas F. Crocker
Thomas F. Crocker
JEJoie Ensor
Joie Ensor
NLNatalie Lam
Natalie Lam
MJMagda Jordão
Magda Jordão
RBRam Bajpai
Ram Bajpai
ACAndrew Clegg
Andrew Clegg
Objective To synthesise evidence of the effectiveness of community based complex interventions, grouped according to their intervention components, to sustain independence for older people. Design Systematic review and network meta-analysis. Data sources Medline, Embase, CINAHL, PsycINFO, CENTRAL, clinicaltrials.gov, and International Clinical Trials Registry Platform from inception to 9 August 2021 and reference lists of included studies. Eligibility criteria Randomised controlled trials or cluster randomised controlled trials with ≥24 weeks’ follow-up studying community based complex interventions for sustaining independence in older people (mean age ≥65 years) living at home, with usual care, placebo, or another complex intervention as comparators. Main outcomes Living at home, activities of daily living (personal/instrumental), care home placement, and service/economic outcomes at 12 months. Data synthesis Interventions were grouped according to a specifically developed typology. Random effects network meta-analysis estimated comparative effects; Cochrane’s revised tool (RoB 2) structured risk of bias assessment. Grading of recommendations assessment, development and evaluation (GRADE) network meta-analysis structured certainty assessment. Results The review included 129 studies (74 946 participants). Nineteen intervention components, including “multifactorial action from individualised care planning” (a process of multidomain assessment and management leading to tailored actions), were identified in 63 combinations. For living at home, compared with no intervention/placebo, evidence favoured multifactorial action from individualised care planning including medication review and regular follow-ups (routine review) (odds ratio 1.22, 95% confidence interval 0.93 to 1.59; moderate certainty); multifactorial action from individualised care planning including medication review without regular follow-ups (2.55, 0.61 to 10.60; low certainty); combined cognitive training, medication review, nutritional support, and exercise (1.93, 0.79 to 4.77; low certainty); and combined activities of daily living training, nutritional support, and exercise (1.79, 0.67 to 4.76; low certainty). Risk screening or the addition of education and self-management strategies to multifactorial action from individualised care planning and routine review with medication review may reduce odds of living at home. For instrumental activities of daily living, evidence favoured multifactorial action from individualised care planning and routine review with medication review (standardised mean difference 0.11, 95% confidence interval 0.00 to 0.21; moderate certainty). Two interventions may reduce instrumental activities of daily living: combined activities of daily living training, aids, and exercise; and combined activities of daily living training, aids, education, exercise, and multifactorial action from individualised care planning and routine review with medication review and self-management strategies. For personal activities of daily living, evidence favoured combined exercise, multifactorial action from individualised care planning, and routine review with medication review and self-management strategies (0.16, −0.51 to 0.82; low certainty). For homecare recipients, evidence favoured addition of multifactorial action from individualised care planning and routine review with medication review (0.60, 0.32 to 0.88; low certainty). High risk of bias and imprecise estimates meant that most evidence was low or very low certainty. Few studies contributed to each comparison, impeding evaluation of inconsistency and frailty. Conclusions The intervention most likely to sustain independence is individualised care planning including medicines optimisation and regular follow-up reviews resulting in multifactorial action. Homecare recipients may particularly benefit from this intervention. Unexpectedly, some combinations may reduce independence. Further research is needed to investigate which combinations of interventions work best for different participants and contexts. Registration PROSPERO CRD42019162195.

1 March 2021 in Health Technology Assessment
Verified
Journal Article
Closed access
PDF file
RGRebecca Gathercole
Rebecca Gathercole
RBRosie Bradley
Rosie Bradley
EHEmma Harper
Emma Harper
LDLucy Davies
Lucy Davies
LPLynn Pank
Lynn Pank
RHRobert Howard
Robert Howard
Background: Assistive technology and telecare have been promoted to manage the risks associated with independent living for people with dementia, but there is limited evidence of their effectiveness.Objectives: This trial aimed to establish whether or not assistive technology and telecare assessments and interventions extend the time that people with dementia can continue to live independently at home and whether or not they are cost-effective. Caregiver burden, the quality of life of caregivers and of people with dementia and whether or not assistive technology and telecare reduce safety risks were also investigated.Design: This was a pragmatic, randomised controlled trial. Blinding was not undertaken as it was not feasible to do so. All consenting participants were included in an intention-to-treat analysis.Setting: This trial was set in 12 councils in England with adult social services responsibilities.Participants: Participants were people with dementia living in the community who had an identified need that might benefit from assistive technology and telecare.Interventions: Participants were randomly assigned to receive either assistive technology and telecare recommended by a health or social care professional to meet their assessed needs (a full assistive technology and telecare package) or a pendant alarm, non-monitored smoke and carbon monoxide detectors and a key safe (a basic assistive technology and telecare package).Main outcome measures: The primary outcomes were time to admission to care and cost-effectiveness. Secondary outcomes assessed caregivers using the 10-item Center for Epidemiological Studies Depression Scale, the State–Trait Anxiety Inventory 6-item scale and the Zarit Burden Interview.Results: Of 495 participants, 248 were randomised to receive full assistive technology and telecare and 247 received the limited control. Comparing the assistive technology and telecare group with the control group, the hazard ratio for institutionalisation was 0.76 (95% confidence interval 0.58 to 1.01;p = 0.054). After adjusting for an imbalance in the baseline activities of daily living score between trial arms, the hazard ratio was 0.84 (95% confidence interval 0.63 to 1.12;p = 0.20). At 104 weeks, there were no significant differences between groups in health and social care resource use costs (intervention group – control group difference: mean –£909, 95% confidence interval –£5336 to £3345) or in societal costs (intervention group – control group difference: mean –£3545; 95% confidence interval –£13,914 to £6581). At 104 weeks, based on quality-adjusted life-years derived from the participant-rated EuroQol-5 Dimensions questionnaire, the intervention group had 0.105 (95% confidence interval –0.204 to –0.007) fewer quality-adjusted life-years than the control group. The number of quality-adjusted life-years derived from the proxy-rated EuroQol-5 Dimensions questionnaire did not differ between groups. Caregiver outcomes did not differ between groups over 24 weeks.Limitations: Compliance with the assigned trial arm was variable, as was the quality of assistive technology and telecare needs assessments. Attrition from assessments led to data loss additional to that attributable to care home admission and censoring events.Conclusions: A full package of assistive technology and telecare did not increase the length of time that participants with dementia remained in the community, and nor did it decrease caregiver burden, depression or anxiety, relative to a basic package of assistive technology and telecare. Use of the full assistive technology and telecare package did not increase participants’ health and social care or societal costs. Quality-adjusted life-years based on participants’ EuroQol-5 Dimensions questionnaire responses were reduced in the intervention group compared with the control group; groups did not differ in the number of quality-adjusted life-years based on the proxy-rated EuroQol-5 Dimensions questionnaire.Future work: Future work could examine whether or not improved assessment that is more personalised to an individual is beneficial.Trial registration: Current Controlled Trials ISRCTN86537017.Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment; Vol. 25, No. 19. See the NIHR Journals Library website for further project information.

23 January 2021 in Age and Ageing
Verified
Journal Article
Open access
PDF file
RHRobert Howard
Robert Howard
RGRebecca Gathercole
Rebecca Gathercole
RBRosie Bradley
Rosie Bradley
EHEmma Harper
Emma Harper
LDLucy Davis
Lucy Davis
RGRichard Gray
Richard Gray
The use of assistive technology and telecare (ATT) has been promoted to manage risks associated with independent living in people with dementia but with little evidence for effectiveness. Participants were randomly assigned to receive an ATT assessment followed by installation of all appropriate ATT devices or limited control of appropriate ATT. The primary outcomes were time to institutionalisation and cost-effectiveness. Key secondary outcomes were number of incidents involving risks to safety, burden and stress in family caregivers and quality of life. Participants were assigned to receive full ATT (248 participants) or the limited control (247 participants). After adjusting for baseline imbalance of activities of daily living score, HR for median pre-institutionalisation survival was 0.84; 95% CI, 0.63 to 1.12; P = 0.20. There were no significant differences between arms in health and social care (mean -£909; 95% CI, -£5,336 to £3,345, P = 0.678) and societal costs (mean -£3,545; 95% CI, -£13,914 to £6,581, P = 0.499). ATT group members had reduced participant-rated quality-adjusted life years (QALYs) at 104 weeks (mean − 0.105; 95% CI, −0.204 to −0.007, P = 0.037) but did not differ in QALYs derived from proxy-reported EQ-5D. Fidelity of the intervention was low in terms of matching ATT assessment, recommendations and installation. This, however, reflects current practice within adult social care in England. Time living independently outside a care home was not significantly longer in participants who received full ATT and ATT was not cost-effective. Participants with full ATT attained fewer QALYs based on participant-reported EQ-5D than controls at 104 weeks.

24 October 2024 in PLOS Mental Health
Verified
Journal Article
Open access
PDF file
NLNatalie Lam
Natalie Lam
SFSophie Fairweather
Sophie Fairweather
DLDan Lewer
Dan Lewer
MPMatthew Prescott
Matthew Prescott
PUPriyanjan Undugoda
Priyanjan Undugoda
RWRuth Wadman
Ruth Wadman
Adverse childhood experiences (ACEs) are thought to have negative effects on mental health and well-being in adolescence. The definition of ACEs varies between studies, and their measurement is mainly based on questionnaires designed for adults to recall their childhood. This scoping review aimed to explore the research methods and findings from studies that quantitatively analysed the association between ACEs and mental health, behaviour, and educational performance in adolescence (ages 12–17). We sought to map and hypothesise the links or mechanisms between ACEs and these psychosocial outcomes by narrative synthesis of the methodologies and findings of the included studies, appraised with the Cambridge Quality Checklist. We searched MEDLINE, EMBASE, and PsychINFO from 1998 to July 2023 for relevant studies. We identified twenty studies that measured twenty-seven “ACEs” during childhood (ages 0–17), including abuse, neglect, household dysfunction, bullying, and other adversities. The definition of and measurement tools for ACEs and the analysis techniques were heterogeneous. ACEs were commonly analysed as the exposure of interest with factors around the child and family as confounders. Statistical techniques included regression modelling, mediation analysis, structural equation modelling, and decision tree classification. Eighteen studies estimated the cumulative effects of ACEs, either as ACEs count/score or latent classes; and four studies estimated individual ACE effects. Cumulative ACEs and most individual ACEs were positively associated with increased probabilities of negative adolescent psychosocial outcomes. Measuring ACEs during childhood and the associated impacts on adolescents appeared feasible in longitudinal studies and surveys. Heterogeneous ACE classification, psychometric properties of measurement tools, and the ACE score analysis approach limit the comparability and interpretation of findings. Future studies into the prevention or effects of ACEs on adolescent well-being and development should address factors leading to ACEs or mitigating their impacts on adolescent psychosocial development, and use triangulation in the research of ACEs.

1 January 2019 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
KFKirsty Forsyth
Kirsty Forsyth
CHCatherine Henderson
Catherine Henderson
LDLucy Davis
Lucy Davis
ARAnusua Singh Roy
Anusua Singh Roy
BDBarbara Dunk
Barbara Dunk
RHRobert Howard
Robert Howard
Introduction: The objective of this study was to define current assistive technology and telecare (ATT) practice for people with dementia living at home. Methods: This is a randomized controlled trial (N = 495) of ATT assessment and ATT installation intervention, compared with control (restricted ATT package). ATT assessment and installation data were collected. Qualitative work identified value networks delivering ATT, established an ATT assessment standard. Results: ATT was delivered by public and not‐for‐profit telecare networks. ATT assessments showed 52% fidelity to the ATT assessment standard. Areas of assessment most frequently leading to identifying ATT need were daily activities (93%), memory (89%), and problem‐solving (83%). ATT needs and recommendations were weakly correlated (τ = 0.242; P < .000), with ATT recommendations and installations moderately correlated (τ = −0.470; P < .000). Half (53%) of recommended technology was not installed. Safety concerns motivated 38% of installations. Discussion: Assessment recommendations were routinely disregarded at the point of installation. ATT was commonly recommended for safety and seldom for supporting leisure.